Advanced prostate cancer is associated with a decrease in serum luteinizing hormone

European Urology

Volumn 38, Issue 3, 2000, Pages 243-249

  Hilz, Helmuth ^a   Graefen, Markus ^a   Noldus, Joachim ^a   Hammerer, Peter ^a   Knabbe, Cornelius ^a   Huland, Edith ^a   Huland, Hartwig ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Androgens; LH homeostasis; Prostate cancer; Prostatectomy; PSA LH ratio; Tumor progression

Indexed keywords

ANDROSTANOLONE; LUTEINIZING HORMONE; PROSTATE SPECIFIC ANTIGEN; TESTOSTERONE;

ADULT; ADVANCED CANCER; AGED; ANDROGEN BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; HUMAN; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATECTOMY; TUMOR GROWTH;

EID: 0033846637     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1159/000020288     Document Type: Article

References (29)